| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5705233 | Ophthalmology | 2017 | 11 Pages |
Abstract
A slow-release dexamethasone implant did not improve the primary anatomic success rate in eyes undergoing vitrectomy surgery with silicone oil for PVR. Further clinical trials are indicated to improve anatomic and visual outcomes in these eyes, but this study suggests that there is a greater reduction in CMO observed at 6 months in vitrectomized eyes treated with slow-release dexamethasone.
Keywords
DMCInvestigational medicinal productCMOSD OCTlogMARETDRSIMPiOpIQRcystoid macular edemastandard deviationspectral domain optical coherence tomographyVisual acuityearly treatment diabetic retinopathy studyPVRadverse eventconfidence intervalIntraocular pressurelogarithm of the minimum angle of resolutioninterquartile rangeodds ratioProliferative vitreoretinopathyData Monitoring Committee
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Philip J. BMedSci, FRCOphth, Ana MSc, Catey DSc, Wen MSc, Tapiwa M. BSc, Nicola Harris, David G. FRCS(Ed), FRCOphth,